Cutting chemo doses for seniors: help or harm?

NCT ID NCT07369596

Recruiting now Knowledge-focused Sponsor: University of Malaya Source: ClinicalTrials.gov ↗

First seen Jan 27, 2026 · Last updated Jun 11, 2026 · Updated 26 times

Summary

This study looks at whether giving older adults (65+) with advanced lung cancer a lower dose of chemotherapy affects how long they live. Researchers will compare survival between those who received standard doses and those who got reduced doses. The goal is to find out if dose reductions are safe and effective for this age group.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hospital Tengku Ampuan Afzan
RECRUITING

Kuantan, Pahang, Malaysia

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Hospital Wanita dan Kanak-Kanak Sabah
RECRUITING

Kota Kinabalu, Sabah, Malaysia

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Queen Mary Hospital, The University of Hong Kong
RECRUITING

Hong Kong, Hong Kong

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••
Universiti Malaya Medical Centre
RECRUITING

Kuala Lumpur, Malaysia

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

NON SMALL CELL LUNG CARCINOMA NSCLC NON SMALL CELL LUNG CARCINOMA NSCLC